BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, Q2 2026
-7,856
Period ended Jun 30, 2026
Change on a year earlier
-7.7%
-8,511 in Q2 2025
History
43 quarters
Since Q4 2015
Sources
41
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accumulated deficit ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -7,856 | -7.7% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | -8,093 | -6.0% | Form 10-Q (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | -8,320 | -3.3% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | -8,386 | -0.8% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | -8,511 | +2.1% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | -8,606 | +4.8% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | -8,607 | +8.1% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 30, 2024 | -8,455 | +11.3% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | -8,334 | +6.7% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -8,213 | +10.6% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | -7,962 | +12.5% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | -7,595 | +14.5% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | -7,810 | +30.8% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | -7,429 | +37.6% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | -7,080 | +39.5% | Form 10-K (filed 2023-02-27) ↗ |
| Q3 2022 | Sep 30, 2022 | -6,635 | +51.5% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | -5,972 | +50.6% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | -5,400 | +54.9% | Form 10-Q (filed 2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | -5,077 | +42.9% | Form 10-Q (filed 2022-11-09) ↗ |
| Q3 2021 | Sep 30, 2021 | -4,380 | +42.2% | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | -3,967 | +49.4% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | -3,486 | +50.3% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | -3,553 | +81.6% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | -3,080 | +96.5% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | -2,655 | +110.6% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | -2,320 | +97.4% | Form 10-Q (filed 2020-05-11) ↗ |
| Q4 2019 | Dec 31, 2019 | -1,956 | +94.2% | Form 10-K (filed 2020-03-02) ↗ |
| Q3 2019 | Sep 30, 2019 | -1,568 | +112.2% | Form 10-Q (filed 2019-11-12) ↗ |
| Q2 2019 | Jun 30, 2019 | -1,260 | +111.9% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | -1,175 | +168.2% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | -1,007 | +204.8% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | -739 | +219.6% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | -595 | +70.7% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | -438 | +52.1% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | -331 | +39.2% | Form 10-K (filed 2018-02-28) ↗ |
| Q3 2017 | Sep 30, 2017 | -231 | +15.7% | Form 10-Q (filed 2017-11-13) ↗ |
| Q2 2017 | Jun 30, 2017 | -349 | +112.2% | Form 10-Q (filed 2017-08-09) ↗ |
| Q1 2017 | Mar 31, 2017 | -288 | +105.4% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | -237 | +100.8% | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2016 | Sep 30, 2016 | -200 | – | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2016 | Jun 30, 2016 | -164 | – | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2016 | Mar 31, 2016 | -140 | – | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2015 | Dec 31, 2015 | -118 | – | Form 10-Q (filed 2016-05-12) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Accumulated deficit ($M) ($M), quarterly Q4 2015–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_re
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.